Table of contents
General:books
composite lymphoma
flow cytometry
molecular overview (pending)
staging-primary cutaneous
WHO 2017 classification-B cell
WHO classification-GI hematolymphoid tumors
WHO classification T/NK cell
WHO 2022 & ICC-B cell
WHO 2022 & ICC-T / NK cell
Mature B cell neoplasms
Small B cell lymphomas with a circulating component:CLL / SLL
Richter syndrome
B cell monoclonal lymphocytosis
prolymphocytic leukemia
hairy cell leukemia
hairy cell leukemia variant
Small B cell lymphomas with lymphoplasmacytic differentiation / marginal zone lymphomas:lymphoplasmacytic lymphoma
MALT-marginal zone
marginal zone-general
marginal zone-nodal
pediatric nodal marginal zone lymphoma
Follicular lymphoma:follicular-usual
follicular lymphoma-duodenal type
follicular neoplasia in situ
pediatric type
primary follicular lymphoma-testis
unusual morphologic patterns of follicular lymphoma
Mantle cell lymphoma:MCL-classic
in situ mantle cell neoplasia
MCL-leukemic nonnodal
MCL-aggressive variants
DLBCL and large B cell lymphomas with high grade features:DLBCL, NOS
Burkitt lymphoma
Large B cell lymphoma with 11q aberration
DLBCL / high grade B cell lymphoma with MYC and BCL2 rearrangements
High grade B cell lymphoma, NOS
Large B cell lymphomas-special subtypes:primary mediastinal
LBCL with IRF4
T cell / histiocyte rich
nodular lymphocyte predominant B cell lymphoma / nodular lymphocyte predominant Hodgkin lymphoma
EBV+ DLBCL
fibrin associated large B cell lymphoma
fluid overload associated LBCL
mediastinal gray zone lymphoma (pending)
pyothorax associated
lymphomatoid granulomatosis
plasmablastic lymphoma
intravascular
ALK+ LBCL
primary effusion lymphoma
Cutaneous B cell lymphomas:primary cutaneous DLBCL-leg
primary cutaneous follicle center lymphoma
primary cutaneous marginal zone lymphoma
Splenic B cell lymphomas and leukemias:splenic B cell leukemia / lymphoma, unclassifiable (pending)
splenic diffuse red pulp
splenic marginal zone
Extranodal organ specific lymphoma:DLBCL-primary testicular
follicular lymphoma-duodenal type
primary follicular lymphoma-testis
primary CNS lymphoma
Posttransplant lymphoproliferative disorders (PTLD):PTLD-polymorphic
PTLD-classic Hodgkin
graft versus host disease
Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation:EBV+ mucocutaneous ulcer
inborn error of immunity-associated lymphoid proliferations and lymphomas
lymphomas arising in immune deficiency / dysregulation
polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation
HHV8 associated lymphoproliferative disorders:HHV8 associated multicentric Castleman disease
HHV8 related DLBCL, NOS
HHV8 related germinotropic lymphoproliferative disorder
Hodgkin lymphoma:nodular lymphocyte predominant B cell lymphoma / nodular lymphocyte predominant Hodgkin lymphoma
classic Hodgkin lymphoma
CHL nodular sclerosis
CHL lymphocyte rich
CHL mixed cellularity
CHL lymphocyte depleted
Mature T/NK cell disorders:T/NK cell disorders-general
T/NK cell disorders with a leukemic component:T prolymphocytic leukemia
T cell large granular lymphocytic leukemia
chronic lymphoproliferative disorders of NK cells
aggressive NK cell leukemia
ATLL
Sézary syndrome
Intestinal:enteropathy associated
intestinal T cell lymphoma, NOS
monomorphic epitheliotropic intestinal
indolent T lymphoproliferative disease of the GI tract
Aggressive NK/T cell disorders:extranodal NK / T cell lymphoma
hepatosplenic T cell lymphoma
peripheral T cell lymphoma, NOS
Anaplastic large cell lymphoma:anaplastic large cell lymphoma, ALK positive
anaplastic large cell lymphoma, ALK negative
breast implant associated ALCL
T follicular helper phenotype:angioimmunoblastic T cell lymphoma
follicular peripheral T cell lymphoma (F-PTCL)
nodal PTCL with a TFH phenotype (pending)
EBV(+) nodal T and NK cell lymphoma (pending)
Cutaneous / soft tissue involvement:lymphomatoid papulosis
mycosis fungoides
mycosis fungoides variants (pending)
primary cutaneous acral CD8+ lymphoproliferative disorder
primary cutaneous anaplastic large cell lymphoma
primary cutaneous CD4+ small / medium
primary cutaneous CD8+ aggressive epidermotropic T cell lymphoma
primary cutaneous gamma delta
primary cutaneous PTCL, NOS (pending)
subcutaneous panniculitis-like T cell lymphoma
Systemic T cell lymphomas presenting in the skin:anaplastic large cell lymphoma, ALK positive
angioimmunoblastic T cell lymphoma
ATLL
extranodal NK / T cell lymphoma
T prolymphocytic leukemia
Pediatric NK/T cell disorders:hydroa vacciniforme-like LPD
systemic chronic active EBV disease (pending)
systemic EBV+ of childhood
Disorders from other chapters:
acute lymphoblastic leukemia / lymphoma
early T cell precursor lymphoblastic leukemia (pending)
NK lymphoblastic leukemia/lymphoma (pending)
T lymphoblastic lymphoma / leukemia
Non-Hodgkin lymphoma stains:
Small B cell initial screening: BCL2 BCL6 CD3 CD20 CD21 Ki67
Refining panel: CD5 CD10 CD23 CD138 cyclin D1 kappa lambda LEF1 SOX11
FISH: CCND1
Aggressive B cell initial screening: BCL6 CD3 CD10 CD20 Ki67 MUM1
Refining panel: ALK BCL2 CD5 CD30 CD138 CMYC EBER HHV8 kappa lambda p53 PAX5
FISH: BCL2 BCL6 MYC IRF4 del(11q)
T / NK cell initial screening: CD3 CD5 CD10 CD20 CD21 CD30 Ki67
Refining panel: ALK BCL2 BCL6 CCR4 CD2 CD4 CD7 CD8 CD25 CD56 CD57 CD103 CXCL13 (pending) CXCR3 EBER GATA3 granzyme B ICOS PD1 perforin (pending) TBX21 / TBET TCL1A TIA1
FISH: ALK1
Hodgkin lymphoma stains: ALK1 BOB1 CD3 CD15 CD20 CD21 CD30 CD45 EBER OCT2 PAX5
Non-Hodgkin lymphoma stains:
Small B cell initial screening: BCL2 BCL6 CD3 CD20 CD21 Ki67
Refining panel: CD5 CD10 CD23 CD138 cyclin D1 kappa lambda LEF1 SOX11
FISH: CCND1
Aggressive B cell initial screening: BCL6 CD3 CD10 CD20 Ki67 MUM1
Refining panel: ALK BCL2 CD5 CD30 CD138 CMYC EBER HHV8 kappa lambda p53 PAX5
FISH: BCL2 BCL6 MYC IRF4 del(11q)
T / NK cell initial screening: CD3 CD5 CD10 CD20 CD21 CD30 Ki67
Refining panel: ALK BCL2 BCL6 CCR4 CD2 CD4 CD7 CD8 CD25 CD56 CD57 CD103 CXCL13 (pending) CXCR3 EBER GATA3 granzyme B ICOS PD1 perforin (pending) TBX21 / TBET TCL1A TIA1
FISH: ALK1
Hodgkin lymphoma stains: ALK1 BOB1 CD3 CD15 CD20 CD21 CD30 CD45 EBER OCT2 PAX5
Index (Alphabetical table of contents)
A-E:aggressive NK cell leukemia
ALK+ LBCL
anaplastic large cell lymphoma, ALK negative
anaplastic large cell lymphoma, ALK positive
angioimmunoblastic T cell lymphoma
ATLL
B cell monoclonal lymphocytosis
breast implant associated ALCL
Burkitt lymphoma
CHL lymphocyte depleted
CHL lymphocyte rich
CHL mixed cellularity
CHL nodular sclerosis
chronic lymphoproliferative disorders of NK cells
classic Hodgkin lymphoma
CLL / SLL
composite lymphoma
DLBCL / high grade B cell lymphoma with MYC and BCL2 rearrangements
DLBCL, NOS
DLBCL-primary testicular
EBV(+) nodal T and NK cell lymphoma (pending)
EBV+ DLBCL
EBV+ mucocutaneous ulcer
enteropathy associated
extranodal NK / T cell lymphoma
F-N:fibrin associated large B cell lymphoma
flow cytometry
fluid overload associated LBCL
follicular lymphoma-duodenal type
follicular neoplasia in situ
follicular peripheral T cell lymphoma (F-PTCL)
follicular-usual
graft versus host disease
hairy cell leukemia
hairy cell leukemia variant
hepatosplenic T cell lymphoma
HHV8 associated multicentric Castleman disease
HHV8 related DLBCL, NOS
HHV8 related germinotropic lymphoproliferative disorder
High grade B cell lymphoma, NOS
hydroa vacciniforme-like LPD
in situ mantle cell neoplasia
inborn error of immunity-associated lymphoid proliferations and lymphomas
indolent T lymphoproliferative disease of the GI tract
intestinal T cell lymphoma, NOS
intravascular
Large B cell lymphoma with 11q aberration
LBCL with IRF4
lymphomas arising in immune deficiency / dysregulation
lymphomatoid granulomatosis
lymphomatoid papulosis
lymphoplasmacytic lymphoma
MALT-marginal zone
marginal zone-general
marginal zone-nodal
MCL-aggressive variants
MCL-classic
MCL-leukemic nonnodal
mediastinal gray zone lymphoma (pending)
molecular overview (pending)
monomorphic epitheliotropic intestinal
mycosis fungoides
mycosis fungoides variants (pending)
nodal PTCL with a TFH phenotype (pending)
nodular lymphocyte predominant B cell lymphoma / nodular lymphocyte predominant Hodgkin lymphoma
O-Z:pediatric nodal marginal zone lymphoma
pediatric type
peripheral T cell lymphoma, NOS
plasmablastic lymphoma
polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation
primary CNS lymphoma
primary cutaneous acral CD8+ lymphoproliferative disorder
primary cutaneous anaplastic large cell lymphoma
primary cutaneous CD4+ small / medium
primary cutaneous CD8+ aggressive epidermotropic T cell lymphoma
primary cutaneous DLBCL-leg
primary cutaneous follicle center lymphoma
primary cutaneous gamma delta
primary cutaneous marginal zone lymphoma
primary cutaneous PTCL, NOS (pending)
primary effusion lymphoma
primary follicular lymphoma-testis
primary mediastinal
prolymphocytic leukemia
PTLD-classic Hodgkin
PTLD-polymorphic
pyothorax associated
Richter syndrome
Sézary syndrome
splenic B cell leukemia / lymphoma, unclassifiable (pending)
splenic diffuse red pulp
splenic marginal zone
staging-primary cutaneous
subcutaneous panniculitis-like T cell lymphoma
systemic chronic active EBV disease (pending)
systemic EBV+ of childhood
T cell / histiocyte rich
T cell large granular lymphocytic leukemia
T prolymphocytic leukemia
T/NK cell disorders-general
unusual morphologic patterns of follicular lymphoma
WHO 2017 classification-B cell
WHO 2022 & ICC-B cell
WHO 2022 & ICC-T / NK cell
WHO classification T/NK cell
WHO classification-GI hematolymphoid tumors
Lymphoma & related disorders books
Auerbach: 2022
Beck: 2021
Cerroni: 2020
Crane: 2021
Dorfman: 2023
Duffield: 2020
Foucar: 2019
Foucar: 2017
Gru: 2023
Hsi: 2017
Hudnall: 2019
IARC: 2017
Jaffe: 2016
Linden: 2015
Medeiros: 2017
Medeiros: 2021
Medeiros: 2023
Molina: 2019
Naeim: 2018
Subtil: 2019
Vasef: 2019
Wang: 2020
Wang: 2018
Find related Pathology books: dermatopathology, hematopathology, immunology / transplant, lab medicine, molecular
